BioMedicine-Taiwan, published by DIGITAL COMMONS BEPRESS, stands as a prominent open-access journal that has been disseminating vital research since 2014. With an ISSN of 2211-8020 and E-ISSN 2211-8039, this journal covers a wide array of disciplines within the biomedical field, reaching researchers and professionals keen on exploring cutting-edge advancements and innovative approaches in biochemistry, genetics, and general medicine. Notably categorized as Q2 in Biochemistry, Genetics and Molecular Biology and Q3 in Medicine for 2023, BioMedicine-Taiwan ranks well in its respective fields, reflecting its commitment to enhancing scholarly communication and knowledge dissemination. Situated in Taiwan, its impact is further highlighted by its Scopus rankings—placing it in the 70th percentile for general medicine and 47th percentile for general biochemistry and molecular biology, showcasing its significance in ongoing biomedical discourse. Researchers, students, and professionals are invited to engage with this invaluable resource to explore the latest findings and developments that shape the future of healthcare and biological sciences.

Photodiagnosis and Photodynamic Therapy is a leading journal published by Elsevier, specializing in the fields of biophysics, dermatology, oncology, and pharmacology. With an impressive Q2 ranking across multiple categories in the 2023 category quartiles, this journal is pivotal for researchers and practitioners aiming to advance their knowledge and expertise in photodiagnostic and therapeutic techniques. Since its inception in 2004, it has provided a critical platform for peer-reviewed articles exploring the latest advancements and applications in light-based treatments. As of 2024, the journal will be fully Open Access, enhancing its accessibility and reach across the scientific community. Located in Amsterdam, Netherlands, this journal's commitment to fostering innovation and collaboration makes it an essential resource for those interested in the intersection of light-based technologies and medicine. With its high visibility in key indexed databases like Scopus, researchers can trust that their contributions will be well-regarded and widely disseminated.

Undersea and Hyperbaric Medicine is a pivotal journal published by the Undersea & Hyperbaric Medical Society Inc., focusing on the advanced field of undersea and hyperbaric medical research. It has served the scientific community since its inception in 1993, and is recognized for its commitment to disseminating peer-reviewed articles that address both the clinical and scientific aspects of hyperbaric medicine and related disciplines. The journal is indexed in various databases and classified in key quartiles, ranking Q3 in Medicine (miscellaneous) and Q4 in Physiology (medical) as of 2023, making it an essential resource for professionals engaged in these specialized areas. Although the journal does not currently offer open access, its implications and contributions to the fields of pulmonary and respiratory medicine and physiology are substantial, with a Scopus rank indicating its relevance despite some competitive challenges. This publication serves as a vital platform for researchers, allows for the exploration of novel therapies, and promotes the dissemination of knowledge critical for advancements in medical practice related to undersea and hyperbaric environments.

ELECTROMAGNETIC BIOLOGY AND MEDICINE, published by Taylor & Francis Inc, is a pioneering journal that delves into the intricate relationships between electromagnetic fields and biological systems. With an ISSN of 1536-8378 and an E-ISSN of 1536-8386, this esteemed publication has been serving the scientific community since its inception in 1982. As a vital resource in the fields of biophysics and medical sciences, it is categorized in the Q3 quartile for both Biophysics and Medicine (miscellaneous) as of 2023, reflecting its significant contributions and robust research output. With Scopus rankings indicating a 61st percentile in Medicine and a 44th percentile in Biophysics, this journal is instrumental for researchers, professionals, and students seeking to explore the multifaceted applications of electromagnetic phenomena in health and medicine. This journal offers access options tailored to enhance visibility and dissemination of research, emphasizing its commitment to advancing knowledge and fostering innovation in this interdisciplinary domain.

The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.

Archives of Physiology and Biochemistry, published by Taylor & Francis Ltd, is a renowned journal that has been pivotal in advancing knowledge and research in the fields of physiology and biochemistry since its inception. With an impact factor reflective of its significant contributions, this journal is categorized in Q2 in Medicine (miscellaneous) and Q3 in Physiology, underscoring its relevance and scholarly impact within the scientific community. The journal publishes original research articles, review papers, and innovative methodologies that explore the intricate relationships between physiological functions and biochemical processes. With its commitment to fostering scientific discourse, the Archives of Physiology and Biochemistry serves as an essential resource for researchers, professionals, and students alike, providing insights and evidence that drive forward the frontiers of medical and physiological science. The journal is accessible in both print and online formats, ensuring that critical research reaches a wide audience.

Presse Medicale, published by MASSON EDITEUR, is a prominent French medical journal dedicated to the dissemination of interdisciplinary research and clinical practices within the realm of medicine. With a history spanning over four decades, from 1983 to 2024, this journal has carved a niche for itself in the field, currently ranked Q2 in the Medicine (miscellaneous) category for 2023. It holds an impressive Scopus rank of #442 out of 830 in General Medicine, reflecting its significance and engagement within the global medical community. The journal operates under a traditional access model, ensuring that high-quality peer-reviewed articles are available to professionals and academics aiming to deepen their understanding of various medical topics. By fostering dialogue among experts and providing timely insights into emerging trends and findings, Presse Medicale remains an essential resource for researchers, clinicians, and students alike, contributing to the advancement of medical knowledge in a rapidly evolving landscape.

Current Stem Cell Research & Therapy, published by Bentham Science Publishers Ltd, is a leading journal dedicated to advancing the field of stem cell research. With an ISSN of 1574-888X and an E-ISSN of 2212-3946, this journal has been a valuable resource since its inception in 2006 and continues to broaden its scope through 2024. Recognized in the Q2 quartile for Medicine (miscellaneous) and ranked in the 66th percentile among its peers, the journal plays a crucial role in disseminating high-quality, peer-reviewed research that explores both the therapeutic and biological implications of stem cells. Located in the United Arab Emirates, Current Stem Cell Research & Therapy embraces a global audience of researchers, professionals, and students, providing a vibrant platform for discourse and innovation. While the journal offers subscription-based access, it remains committed to enhancing the scientific community's understanding of stem cell therapy and its applications across various medical fields.

Phytotherapy Research, a distinguished journal published by Wiley, stands at the forefront of the pharmacological literature, delivering essential insights into the therapeutic potential of plant-based interventions. With its ISSN 0951-418X and E-ISSN 1099-1573, the journal has firmly established itself since its inception in 1987, now converging into its 2024 volume. Notably positioned in the Q1 category of Pharmacology and ranked #22 out of 313 journals in the field, it boasts a remarkable 93rd percentile rating according to Scopus. While the journal adheres to subscription-based access, it remains a crucial repository of high-quality research findings that support the understanding and advancement of herbal medicines and phytotherapeutics. This journal serves as an invaluable resource for researchers, healthcare professionals, and students alike, fostering a deeper exploration of the synergistic relationship between nature and medicine and promoting evidence-based practices in the field.

Diving and Hyperbaric Medicine is a premier journal published by the SOUTH PACIFIC UNDERWATER MEDICAL SOCIETY that focuses on the critical intersection of diving medicine and hyperbaric physiology. With an ISSN of 1833-3516, this journal has become an essential resource for researchers, healthcare professionals, and students interested in the fields of public health, environmental health, and occupational health, as reflected in its Q3 ranking in the 2023 category quartiles. Since its inception in 2006, it has consistently provided high-quality peer-reviewed articles that address the latest clinical practices, research findings, and technological advancements in underwater medicine. Supporting a broad readership with its commitment to knowledge dissemination, Diving and Hyperbaric Medicine serves as a valuable platform for sharing innovations and challenges faced in hyperbaric treatments and diving safety protocols. Although not currently open access, it remains a recognized journal with significant contributions to the field, housed in Australia, at C/O AUSTRALIAN & NEW ZEALAND COLL ANAESTHETISTS, 630 ST KILDA RD, MELBOURNE VIC 3004, AUSTRALIA. Join the academic discourse and explore insights vital for improving diving safety and health outcomes in this dynamic domain.